Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon 25000 in Post-Gastrectomy Patients
NCT00160186Phase 4Completed
- Sponsor
- Solvay
- Start
- Dec 2003
- Primary completion
- May 2006
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
Phase 4, randomised, double-blind trial in intestinal malabsorption comparing Creon with Placebo (2 arms). Primary endpoint: Body Mass Index at 6 months. Started Dec 2003; status: completed.
02
Drugs
pancrelipase
03
Conditions
intestinal malabsorption
Beyond the preview
Go deeper on NCT00160186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160186.